EGFR inhibition as a therapy for head and neck squamous cell carcinoma

By Loeffler-Ragg Judith   Schwentner Ilona   Sprinzl Georg M   Zwierzina Heinz  

Expert Opinion on Investigational Drugs, Vol. 17, Iss. 10, 2008-10 ,pp. : 1517-1531

Informa Healthcare

Access to resources Recommend Favorite

EGFR targeting drugs in the treatment of head and neck squamous cell carcinoma

By Sundvall Maria   Karrila Anna   Nordberg Janne   Grénman Reidar   Elenius Klaus  

Expert Opinion on Emerging Drugs, Vol. 15, Iss. 2, 2010-06 ,pp. : 185-201

Informa Healthcare

Access to resources Recommend Favorite

Dual EGFR and COX-2 Inhibition as a Novel Approach to Targeting Head and Neck Squamous Cell Carcinoma

By  

Current Cancer Drug Targets, Vol. 9, Iss. 8, 2009-12 ,pp. : 931-937

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmacotherapy for squamous-cell carcinoma of the head and neck

By Papaspyrou Giorgos   Werner Jochen A   Dietz Andreas  

Expert Opinion on Pharmacotherapy, Vol. 12, Iss. 3, 2011-02 ,pp. : 397-409

Informa Healthcare

Access to resources Recommend Favorite

Afatinib in the treatment of head and neck squamous cell carcinoma

By Ferrarotto Renata   Gold Kathryn A  

Expert Opinion on Investigational Drugs, Vol. 23, Iss. 1, 2014-01 ,pp. : 135-143

Informa Healthcare

Access to resources Recommend Favorite